These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Pharmacological Characterization of the Imipridone Anticancer Drug ONC201 Reveals a Negative Allosteric Mechanism of Action at the D Free RB; Cuoco CA; Xie B; Namkung Y; Prabhu VV; Willette BKA; Day MM; Sanchez-Soto M; Lane JR; Laporte SA; Shi L; Allen JE; Sibley DR Mol Pharmacol; 2021 Oct; 100(4):372-387. PubMed ID: 34353882 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and binding profile of haloperidol-based bivalent ligands targeting dopamine D(2)-like receptors. Salama I; Löber S; Hübner H; Gmeiner P Bioorg Med Chem Lett; 2014 Aug; 24(16):3753-6. PubMed ID: 25047579 [TBL] [Abstract][Full Text] [Related]
15. A QM protein-ligand investigation of antipsychotic drugs with the dopamine D2 Receptor (D2R). Ekhteiari Salmas R; Serhat Is Y; Durdagi S; Stein M; Yurtsever M J Biomol Struct Dyn; 2018 Aug; 36(10):2668-2677. PubMed ID: 28805144 [TBL] [Abstract][Full Text] [Related]
16. The dopamine D2 receptor dimer and its interaction with homobivalent antagonists: homology modeling, docking and molecular dynamics. Kaczor AA; Jörg M; Capuano B J Mol Model; 2016 Sep; 22(9):203. PubMed ID: 27491852 [TBL] [Abstract][Full Text] [Related]
18. The action of a negative allosteric modulator at the dopamine D Draper-Joyce CJ; Verma RK; Michino M; Shonberg J; Kopinathan A; Klein Herenbrink C; Scammells PJ; Capuano B; Abramyan AM; Thal DM; Javitch JA; Christopoulos A; Shi L; Lane JR Sci Rep; 2018 Jan; 8(1):1208. PubMed ID: 29352161 [TBL] [Abstract][Full Text] [Related]
19. The fourth transmembrane segment forms the interface of the dopamine D2 receptor homodimer. Guo W; Shi L; Javitch JA J Biol Chem; 2003 Feb; 278(7):4385-8. PubMed ID: 12496294 [TBL] [Abstract][Full Text] [Related]